Michael A. Stanga

Substituted 2-pyrones, 2-pyridones, and other congeners of elasnin as potential agents for the treatment of chronic obstructive lung diseases

William C. Groutas, Michael A. Stanga, Michael J. Brubaker et al. · Journal of Medicinal Chemistry · 1985 · 49 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

13C NMR evidence for an enzyme-induced Lossen rearrangement in the mechanism-based inactivation of .alpha.-chymotrypsin by 3-benzyl-N-((methylsulfonyl)oxy)succinimide

William C. Groutas, Michael A. Stanga, Michael J. Brubaker · Journal of the American Chemical Society · 1989 · 43 citations

Life Sciences, Biochemistry, Biocatalysis +9

Isoxazoline derivatives as potential inhibitors of the proteolytic enzymes human leukocyte elastase, cathepsin G and proteinase 3: a structure-activity relationship study

William C. Groutas, R. Venkataraman, Lee S. Chong et al. · Bioorganic & Medicinal Chemistry · 1995 · 39 citations

Life Sciences, Biochemistry, Pharmacology +17

Inhibitors of human neutrophil cathepsin G: Structural and biochemical studies

William C. Groutas, Michael J. Brubaker, Rhadika Venkataraman et al. · Archives of Biochemistry and Biophysics · 1992 · 17 citations

Life Sciences, Biochemistry, Medicinal Chemistry +8

Substituted 2‐Pyrones and 5,6‐Dihydropyrones

William C. Groutas, Tien L. Huang, Michael A. Stanga et al. · Journal of Heterocyclic Chemistry · 1985 · 15 citations

Life Sciences, Chemistry, Pharmacology +5